| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6115048 | Current Opinion in Immunology | 2014 | 6 Pages |
Abstract
- iNKT cells provide innate, cognate help for T-dependent type II antigens.
- iNKT cells provide adaptive, noncognate help for T-D type 1 and T-I antigens.
- Cognate antigen drives splenic iNKT cells to arrest in the MZ then help GC B cells.
- Nanoparticles containing glycolipids are highly efficient activators of iNKT cells.
- Glycolipid and antigen containing nanoparticles are promising vaccine candidates.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Emilie E Vomhof-DeKrey, Jennifer Yates, Elizabeth A Leadbetter,